Elaine O'Hara
Corporate Officer/Principal at NOVAVAX, INC.
Net worth: 61 594 $ as of 2024-04-29
Profile
Elaine O'Hara has held positions as President & Director at Sanofi Pasteur VaxDesign Corp.
and currently holds the position of Chief Strategy Officer at Novavax, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVAVAX, INC.
0.01% | 2024-02-29 | 14,225 ( 0.01% ) | 61 594 $ | 2024-04-29 |
Elaine O'Hara active positions
| Companies | Position | Start |
|---|---|---|
| NOVAVAX, INC. | Corporate Officer/Principal | 2023-02-28 |
Sanofi Pasteur VaxDesign Corp.
 Sanofi Pasteur VaxDesign Corp. Miscellaneous Commercial ServicesCommercial Services Sanofi Pasteur VaxDesign Corp. designs, develops, and manufactures in vitro models of the human immune system. The firm engages in preventing infectious disease by forecasting vaccine responses before clinical trials by providing predictive in vitro immunological models and assays. The company was founded by William Warren in 2004 and is headquartered in Orlando, FL. | President | - |
Training of Elaine O'Hara
| Saint Joseph's University Haub School of Business | Masters Business Admin |
| National University of Ireland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Sanofi Pasteur VaxDesign Corp.
Sanofi Pasteur VaxDesign Corp. Miscellaneous Commercial ServicesCommercial Services Sanofi Pasteur VaxDesign Corp. designs, develops, and manufactures in vitro models of the human immune system. The firm engages in preventing infectious disease by forecasting vaccine responses before clinical trials by providing predictive in vitro immunological models and assays. The company was founded by William Warren in 2004 and is headquartered in Orlando, FL. | Commercial Services |
- Stock Market
- Insiders
- Elaine O'Hara
